Drug eruptionhttps://en.wikipedia.org/wiki/Drug_eruption
Drug eruption yindlela engalunganga yokusabela kweziyobisi kwisikhumba. Uninzi lweziphumo zesikhumba ezibangelwa ngamayeza zithambile kwaye ziyanyamalala xa ichiza eligwenxa lirhoxisiwe. Nangona kunjalo, izifo ezinzulu ngakumbi zinokudibaniswa nokulimala kwamalungu anjengesiBindi okanye umonakalo wezintso. Iziyobisi zinokubangela utshintsho lweenwele kunye nezikhonkwane, zichaphazele i‑mucous membranes, okanye zibangele ukuqumba ngaphandle kokutshintsha kwesikhumba sangaphandle.

Ukuxilongwa kweDrug eruption kwenziwa ikakhulu ngembali yonyango kunye nokuhlolwa kweklinikhi. I‑skin biopsy, iimvavanyo zegazi okanye iimvavanyo ze‑immunological nazo zinokuba luncedo.

Imizekelo yeziyobisi eziqhelekileyo ezibangela i‑Drug eruption zi‑antibiotics kunye nezinye i‑antimicrobial drugs, i‑sulfa drugs, i‑nonsteroidal anti‑inflammatory drugs (NSAIDs), i‑chemotherapy agents for malignancies, anticonvulsants kunye ne‑psychotropic drugs.

Uxilongo kunye noNyango
Ukuba unomkhuhlane (ukunyuka kobushushu bomzimba), kufuneka ufune unyango ngokukhawuleza. Ichiza elirhoxisiweyo kufuneka lipheliswe (umzekelo, antibiotics, non‑steroidal anti‑inflammatory drugs). Ngaphambi kokutyelela esibhedlele, i‑antihistamines yomlomo efana ne‑cetirizine okanye i‑loratadine inokunceda ukuqumba kunye ne‑rash.
#Cetirizine [Zytec]
#LevoCetirizine [Xyzal]
#Loratadine [Claritin]

Uvavanyo lwegazi (CBC, LFT, eosinophil count)
I‑oral steroids kunye ne‑antihistamines kunye nomyalelo kagqirha

☆ AI Dermatology — Free Service
Kwiziphumo zika-2022 ze-Stiftung Warentest ezivela eJamani, ukwaneliseka kwabathengi ngeModelDerm bekungaphantsi kancinci kunokubonisana nge-telemedicine ehlawulweyo.
  • Drug eruption ibonakala ngokuchaphazela umzimba wonke.
  • Kwiimeko apho kuchaphazela umzimba ngokubanzi, ukuxilongwa kwe‑Drug eruption kufuneka kuthathelwe ingqalelo endaweni yokuxilongwa kwe‑dermatitis.
  • i-AGEP (Acute generalized exanthematous pustulosis) luhlobo lwerhashalala yeziyobisi.
References Current Perspectives on Severe Drug Eruption 34273058 
NIH
Ukuchaphazeleka kolusu okubangelwa ngamayeza, okwaziwa ngokuba yi severe cutaneous adverse drug reactions (SCARs), ngamanye amaxesha kunokuba nzima. Ezi ntshukumo, ezibizwa ngokuba yi severe cutaneous adverse drug reactions (SCARs), zithathwa njengomngcipheko wobomi. Ziquka iimeko ezifana ne-Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), acute generalized exanthematous pustulosis (AGEP), kunye ne-drug reaction with eosinophilia and systemic symptoms (DRESS). Ngelixa i-SCARs zinqabile, malunga ne-2% yezigulana ezilaliswe esibhedlele ezibhekene nazo.
Adverse drug reactions involving the skin are commonly known as drug eruptions. Severe drug eruption may cause severe cutaneous adverse drug reactions (SCARs), which are considered to be fatal and life-threatening, including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), acute generalized exanthematous pustulosis (AGEP), and drug reaction with eosinophilia and systemic symptoms (DRESS). Although cases are relatively rare, approximately 2% of hospitalized patients are affected by SCARs.
 Fixed drug eruption - Case reports 35918090 
NIH
Umfazi oneminyaka engama-31 ubudala wafika kwicandelo le-dermatology enebala elibomvu elingenabuhlungu phezu konyawo lwasekunene. Uthathe idosi enye ye-doxycycline (100 mg) ngosuku olwandulela, elandelwa unyango lwe-picosecond laser lwezivubeko zamaqhakuva. Kunyaka odlulileyo, waphinda waba nengxaki efanayo kwindawo eyongezelelweyo emva kokuthatha idosi efanayo ye-doxycycline emva kweenyango ze-laser. Akabikho imbali ebalulekileyo yezonyango, kwaye akanazo ezinye iimpawu ezifana nomkhuhlane, ukuxhaphaza, okanye ubuhlungu emzimbeni wonke.
A 31-year-old woman presented to the dermatology department with an asymptomatic erythematous patch on the dorsum of her right foot. She had taken 1 dose of doxycycline (100 mg) the previous day as empirical treatment after picosecond laser treatment for acne scars. She had had a similar episode the previous year on the same site, after taking the same dose of doxycycline after laser treatment. She had no notable medical history, and no other local or systemic symptoms, including fever.
 Stevens-Johnson Syndrome 29083827 
NIH
Stevens-Johnson syndrome (SJS) kunye ne toxic epidermal necrolysis (TEN) ziintlobo ezimbini zokusabela kolusu okumandundu, okwahlukileyo kwezinye iimeko zolusu ezifana ne-erythema multiforme enkulu kunye ne-staphylococcal scalded skin syndrome, kunye nokusabela kweziyobisi. SJS/TEN yindlela enqabileyo nenzima yokusabela ebangela ukonakaliswa kwesikhumba kunye nenwebu yamafinya, amaxesha amaninzi, kukho iimpawu zenkqubo. Ngaphezulu kwe-80% yeziganeko zibangelwa ngamayeza.
Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN) are variants of the same condition and are distinct from erythema multiforme major staphylococcal scalded skin syndrome­, and other drug eruptions. Stevens-Johnson syndrome/toxic epidermal necrolysis is a rare, acute, serious, and potentially fatal skin reaction in which there are sheet-like skin and mucosal loss accompanied by systemic symptoms. Medications are causative in over 80% of cases.